|Articles|July 1, 2006
- Special Issues-07-01-2006
- Volume 0
- Issue 0
European Clinical Trial Regulations Undergo a Slow Revolution
Implementation of the EU Directive proves to be challenging as regulatory variations among member states continue and questions remain unanswered.
Advertisement
Articles in this issue
over 19 years ago
Analytical Instrument Qualificationover 19 years ago
GMP and Phase I Clinical Trials: Streamlining the Critical Path?over 19 years ago
Team Effortover 19 years ago
Rated PG: Pharmaceutical Guidance Suggestedover 19 years ago
Moving Biotech Products from CBER to CDER: A Work in Progressover 19 years ago
New Climateover 19 years ago
2006: A Regulatory Odysseyover 19 years ago
CDER?s Division of Post-Marketing Evaluation for Quality AssessmentNewsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on LCGC International
1
Executive Summary: Fully Automated Sample Preparation Workflow for the GC-MS/MS Detection of Artificial Sweeteners
2
Advanced LC–MS/MS Detection of Acrylamide in Potato Chips Explores Potential Cancer Risks
3
LCGC Blog: Updates from the ACS SCSC for the Separation Science Community
4
David S. Hage on Emerging Trends in Separation Science and Bioanalysis
5
